Cytokine-Based Tumor Immunotherapy
The use of immunostimulant monoclonal antibodies has revolutionized the treatment of cancer. To obtain the maximum potential from these treatments that stimulate the immune system, it is necessary to develop drugs based on molecules that mediate communication between the cells of the immune system: cytokines. The development of safe, effective drugs based on cytokines requires a thorough knowledge of the biology of these molecules and the design of sophisticated strategies to improve their therapeutic properties. This is the goal of the cytokine-based tumor immunotherapy group.